Patent & IP news for January 16, 2015

Continued vague guidance on patentability of software from ocpatentlawyer.com

Bottom line: In Ultramercial v. Hulu (Fed. Cir. 2014), the Federal Circuit continued to provide vague guidance as to the patentability of software, specifically, whether a claimed invention is an unpatentable abstract idea.  The Federal ...

Share via E–mail | Twitter | Facebook

Friday fantasies from ipkitten.blogspot.com

Forthcoming events.  Here's your regular reminder of the virtues of checking the IPKat's Forthcoming Events page from time to time.  Some events are free and/or are sponsored by the IPKat or his ...

Share via E–mail | Twitter | Facebook

GoPro and the Apple patent: buy on the rumour, sell on the fact? from ipkitten.blogspot.com

Except for areas such as pharmaceuticals, chemicals, and chemical processes, the granting of a one-off patent is usually not a market-moving event. One need only think of telecoms, semiconductors and the like, where multiple patents ...

Share via E–mail | Twitter | Facebook

PTAB Update -- No Institution of CBM Patent Review for Jazz's Orange-Book Listed Patents from www.patentdocs.org

By Andrew Williams -- On January 13, 2015, the Patent Trial and Appeal Board ("PTAB" or "Board") denied institution of four covered business method ("CBM") patent review petitions filed by Par Pharmaceutical, Inc. ("Par"), Roxane Laboratories ...

Share via E–mail | Twitter | Facebook

Ericsson may demand 1.5% of Apple's sales from LTE-compatible iPhones and iPads for its patents from www.fosspatents.com

This is a follow-up to yesterday's post on the dispute between Apple and Ericsson over standard-essential patent royalties. I published Ericsson's complaint first because, though it was filed two days later, it appeared ...

Share via E–mail | Twitter | Facebook

Gilead To Appeal India Patent Rejection, Hails Regulatory Approval from www.ip-watch.org

Pharmaceutical manufacturer Gilead has given its side to this week's story of the rejection of its patent on a hepatitis C treatment in India, and it insists it will prevail in making its medicines ...

Share via E–mail | Twitter | Facebook

Webinar on IP and Intangible Capital from www.athenaalliance.org

On Wednesday, January 21 at 11:00 EST I will be presenting a webinar with Mary Adams on "Maximizing IP Value (through understanding intangible capital)". The webinar is being hosted by the IP consulting group ...

Share via E–mail | Twitter | Facebook

Daimler Does Not Preclude General Jurisdiction Based on Compliance With Delaware’s Business Registration Requirement from docketreport.blogspot.com

Reaching a different conclusion than Judge Sleet, Judge Stark denied defendants' motion to dismiss plaintiff's ANDA infringement action against a parent defendant for lack of personal jurisdiction and rejected the argument that Daimler AG ...

Share via E–mail | Twitter | Facebook

State of Mississippi goes after Vinod Khosla in KiOR matter from ipbiz.blogspot.com

From the Sun-Herald Biloxi newspaper:



JACKSON -- The state of Mississippi has sued billionaire Vinod Khosla and others, saying they knew long ago that bankrupt biofuel firm KiOR had poor prospects for success, but misled the ...

Share via E–mail | Twitter | Facebook

USPTO Too Broad in its Broadest Reasonable Interpretation from patentlyo.com

by Dennis Crouch Stoller holds several patents directed to a winterizing golf course greens.  In particular, Stoller’s approach is to roll-out a rubber blanket over the turf.  His most recent patent application was rejected ...

Share via E–mail | Twitter | Facebook